Wei Ziping is the founder of BlissBio. BlissBio has raised $76M in total funding. Latest round: Series B. Based in Hangzhou, China.
Wei Ziping (also known as Ziping Wei) is the Chief Executive Officer of Bliss Biopharmaceutical (BlissBio), a clinical-stage biopharmaceutical company focused on developing antibody-drug conjugates for cancer treatment. He has guided the company through multiple financing rounds and secured a significant clinical trial collaboration with Eisai.
Full founder directory · Investor directory · Company funding database · Fundraising library